Digital Health

Daniel Ek putting Spotify-scale capital and credibility behind a preventative health scanning startup is a bet that consumers will pay out of pocket for diagnostic imaging the NHS and most insurers won't proactively offer. The raise values Neko Health as a serious infrastructure play, not a boutique clinic chain, with ambitions to build scanning centres at a density that makes the model work on throughput rather than premium pricing alone. The tension is regulatory: body scanning at consumer scale raises exactly the kind of overdiagnosis and false-positive concerns that have made the NHS and equivalent European systems cautious about population-level imaging. If Neko can show its scans reduce downstream healthcare costs rather than just generate anxious follow-up appointments, it has a real moat. If it can't, this is an expensive bet on the worried well.